M&A Deal Summary

Invitrogen Acquires CellzDirect

On January 11, 2008, Invitrogen acquired life science company CellzDirect for 57M USD

Acquisition Highlights
  • This is Invitrogen’s 2nd transaction in the Life Science sector.
  • This is Invitrogen’s 2nd largest (disclosed) transaction.
  • This is Invitrogen’s 3rd transaction in the United States.
  • This is Invitrogen’s 1st transaction in North Carolina.

M&A Deal Summary

Date 2008-01-11
Target CellzDirect
Sector Life Science
Buyer(s) Invitrogen
Deal Type Add-on Acquisition
Deal Value 57M USD

Target

CellzDirect

Durham, North Carolina, United States
CellzDirect, Inc. is a bioscience company.

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Invitrogen

Carlsbad, California, United States

website


Category Company
Sector Life Science
DESCRIPTION

Invitrogen Corp. develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities.


DEAL STATS #
Overall 4 of 5
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 4 of 4
State (North Carolina) 1 of 1
Country (United States) 3 of 4
Year (2008) 1 of 2
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-12 BioReliance

Rockville, Maryland, United States

BioReliance Corp. provides critical services that include biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics, and other life science customers worldwide.

Sell $210M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-11 Applied Biosystems

Foster City, California, United States

Applied Biosystems, Inc. is a provider of technology services for pharmaceutical industry.

Buy $7M